Skip to main content
Department of Medicine

Active Studies

Enhanced Pertussis Surveillance (EPS)

Pertussis (whooping cough) is a highly contagious respiratory disease caused by Bordetella pertussis, with infants at greatest risk for severe complications. Despite widespread vaccination, pertussis cases are rising in the U.S., making continued surveillance critical. The Georgia Emerging Infections Program collaborates with the CDC and the Georgia Department of Public Health on Enhanced Pertussis Surveillance (EPS) to monitor disease incidence, study circulating strains, and evaluate vaccine impact. As part of EPS, selected metro Atlanta primary care practices participate as Sentinel Providers, receiving free testing, materials, and support from the Georgia Public Health Laboratory to aid in the detection and reporting of pertussis across all age groups.

 

 

Meningococcal Carriage Study (AMC)

The Georgia Emerging Infections Program, in partnership with Emory University’s HOPE Clinic, is conducting a study to evaluate the effectiveness of azithromycin in eliminating Neisseria meningitidis (meningococcal) carriage among young adults aged 18–25. This research responds to rising antibiotic resistance, particularly to ciprofloxacin, and aims to inform updated public health strategies for meningococcal disease prevention. The study involves screening students near Emory-affiliated campuses, treating identified carriers with a one-time dose of azithromycin, and assessing carriage status post-treatment. It also seeks to establish baseline carriage prevalence, identify serogroups, assess antibiotic susceptibility, and examine risk factors for carriage. Findings will help guide future prophylaxis recommendations amid growing concerns about resistance.


Pneumococcal Carriage Study

The Georgia Emerging Infections Program, in collaboration with Children’s Healthcare of Atlanta, is studying Streptococcus pneumoniae (pneumococcus) carriage in children to better understand how vaccination impacts which serotypes circulate and cause disease. Although pneumococcal vaccines have greatly reduced illness from targeted serotypes, shifts in serotype prevalence and antibiotic resistance have emerged, highlighting the need for continued surveillance. This study collects nasal and nasopharyngeal swabs from children in the emergency department to identify carried serotypes, assess resistance patterns, and compare them with strains causing invasive disease locally. It also examines risk factors for carriage and evaluates swabbing methods to improve detection. Findings will inform future vaccine strategies and public health efforts to reduce pneumococcal disease in children.



HAI Prevalence Studies

Prevalence, a subset of CDC’s EIP Healthcare-Associated Infections Community Interface Activity, engages in special study activities to answer questions and identify trends in HAIs and antimicrobial use in different healthcare settings. These surveys rely on facility partnership and engagement, whether it’s the Hospital Survey or the Nursing Home survey. Data collected from these studies includes HAIs not routinely tracked and/or reportable, which further strengthens the importance and use of the data to public health professionals and healthcare providers to improve patient safety.



Historical Studies

  • Mpox Vaccine Effectiveness (MPX VE)
  • Group B Streptococcus Correlates of Protection (GBS CoP)

  • Healthcare Personnel (HCP) COVID-19 Vaccine Effectiveness (VE)

  • All Sites Staphylococcus aureus Limited Time Expanded Surveillance (aSA)

  • Healthcare Personnel (HCP) COVID-19 Tracking

  • Community-Associated and Carbapenemase-Producing Carbapenem-Resistant Enterobacterales (CA CP CRE) Interviews